Cargando…

5613341 REAL-WORLD CHANGES IN KIDNEY FUNCTION FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANAEMIAS RECEIVING IRON CHELATION THERAPY IN THE US

Detalles Bibliográficos
Autores principales:	Sunil Bhandari, S.B., Emmeline Igboekwe, E.I., Noemi Toiber Temin, N.T.T., Khashayar Azimpour, K.A., Jonathan Alsop, J.A., Caroline Fradette, C.F., Fernando Tricta, F.T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	e-Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112561/ http://dx.doi.org/10.1097/01.HS9.0000928468.25892.5c

Ejemplares similares

PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THERAPY IN PATIENTS WITH THALASSEMIA SYNDROMES OR SICKLE CELL ANEMIA: A SYSTEMATIC LITERATURE REVIEW
por: Kattamis, A., et al.
Publicado: (2022)

P1442: PRACTICE-BASED EVIDENCE: LONG-TERM SAFETY COHORT OF DEFERIPRONE IN PATIENTS WITH SICKLE CELL DISEASE FROM THE US REGISTRY
por: Badawy, Sherif, et al.
Publicado: (2023)

P1511: EFFICACY AND SAFETY OF COMBINATION IRON CHELATION THERAPY WITH DEFERIPRONE AND DEFERASIROX IN PATIENTS WITH Β-THALASSEMIA MAJOR: A SYSTEMATIC LITERATURE REVIEW
por: Piga, A., et al.
Publicado: (2022)

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years
por: Elalfy, Mohsen S., et al.
Publicado: (2022)

S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
por: Inusa, B, et al.
Publicado: (2022)

P1558: EARLY-START DEFERIPRONE IN INFANTS/YOUNG CHILDREN WITH TRANSFUSION-DEPENDENT BETA THALASSEMIA: EVIDENCE FOR IRON SHUTTLING TO TRANSFERRIN—RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (START)
por: Tricta, F., et al.
Publicado: (2022)

S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS
por: Inusa, B, et al.
Publicado: (2022)

The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease
por: Soulières, Denis, et al.
Publicado: (2022)

S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)
por: Elalfy, M, et al.
Publicado: (2022)

Sickle Cell Anaemia and Malaria
por: Luzzatto, Lucio
Publicado: (2012)

Sickle Cell Anæmia in India
Publicado: (1952)

Determinants of academic performance in children with sickle cell anaemia
por: Ezenwosu, Osita U, et al.
Publicado: (2013)

Sickle Cell Anaemia in a Changing World
por: Fottrell, Edward, et al.
Publicado: (2013)

The spatial epidemiology of sickle-cell anaemia in India
por: Hockham, Carinna, et al.
Publicado: (2018)

Lung Function Abnormalities in Sickle Cell Anaemia
por: Dei-Adomakoh, Yvonne A., et al.
Publicado: (2019)

Sickle Cell Anaemia: Progress in Pathogenesis and Treatment
por: Ballas, Samir K.
Publicado: (2012)

Microalbuminuria risks and glomerular filtration in children with sickle cell anaemia in Nigeria
por: Ocheke, I. E., et al.
Publicado: (2019)

Age at Diagnosis of Sickle Cell Anaemia in Lagos, Nigeria
por: Akodu, SO, et al.
Publicado: (2013)

Simulated datasets for population dynamics of sickle cell anaemia
por: Edeki, S.O., et al.
Publicado: (2017)

On artherogenic index of plasma in sickle cell anaemia patients
por: Akinbami, Akinsegun Abduljaleel, et al.
Publicado: (2019)

Rare anaemias, sickle-cell disease and COVID-19
por: Vives Corrons, Joan-Lluis, et al.
Publicado: (2020)

Sideroblastic anaemia in a patient with sickle cell disease
por: Vobugari, Nikitha, et al.
Publicado: (2022)

Sickle Cell Nephropathy and Associated Factors among Asymptomatic Children with Sickle Cell Anaemia
por: Nnaji, Uchenna Modestus, et al.
Publicado: (2020)

Iron Chelation Reduces DNA Damage in Sickle Cell Anemia
por: Al-Khateeb, Rawan S., et al.
Publicado: (2021)

MRI features of intrahepatic extramedullary haematopoiesis in sickle cell anaemia
por: Jelali, Mohamed Ali, et al.
Publicado: (2006)

Serum levels of leptin in Nigerian patients with sickle cell anaemia
por: Iwalokun, Bamidele A, et al.
Publicado: (2011)

Musculoskeletal Manifestations of Sickle Cell Anaemia: A Pictorial Review
por: Ganguly, A., et al.
Publicado: (2011)

SOME ETHICAL ISSUES IN THE PRENATAL DIAGNOSIS OF SICKLE CELL ANAEMIA
por: Fadare, Joseph O.
Publicado: (2009)

Electrocardiographic abnormalities and dyslipidaemic syndrome in children with sickle cell anaemia
por: Adegoke, Samuel Ademola, et al.
Publicado: (2016)

Ischemic Monomeric Neuropathy in a Woman with Sickle Cell Anaemia
por: Agapidou, Alexandra, et al.
Publicado: (2016)

Sarcomatoid Renal Cell Carcinoma in an Adolescent with Sickle Cell Anaemia
por: Ahmad, H. R., et al.
Publicado: (2017)

Coinheritance of B-Thalassemia and Sickle Cell Anaemia in Southwestern Nigeria
por: Vincent, Osunkalu, et al.
Publicado: (2016)

Impact of relative systemic hypertension on the heart in sickle cell anaemia
por: Oni, Opeyemi O., et al.
Publicado: (2020)

Haematological Profile of Children With Sickle Cell Anaemia in Steady State
por: Aliu, Rasaki, et al.
Publicado: (2020)

Iron Deficiency Anaemia among Pre-School Children with Sickle Cell Anaemia: Still a Rare Diagnosis?
por: Akodu, Samuel Olufemi, et al.
Publicado: (2013)

Serum Iron Status of Under-Five Children with Sickle Cell Anaemia in Lagos, Nigeria
por: Akodu, S. O., et al.
Publicado: (2013)

HAEMATOLOGICAL PROFILE AND BLOOD TRANSFUSION PATTERN OF PATIENTS WITH SICKLE CELL ANAEMIA VARY WITH SPLEEN SIZE
por: Fasola, F.A., et al.
Publicado: (2019)

Right ventricular function among South East Nigeria children with sickle cell anaemia
por: Chinawa, Josephat M., et al.
Publicado: (2020)

Clinical and Electrocardiographic Evaluation of Sickle-Cell Anaemia Patients with Pulmonary Hypertension
por: Oguanobi, N. I., et al.
Publicado: (2012)

Experimental Generation of SNP Haplotype Signatures in Patients with Sickle Cell Anaemia
por: Menzel, Stephan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jcsh8poe528mhq54t92v3atb1m